跳到正文
原文
Endpoints News 生物医药· Elizabeth Cairns·· 2026-10-21AI 评分58

GSK贝匹罗韦滨获FDA批准用于慢性肝病毒B治疗

GSK gets FDA approval for hepatitis B drug that offers functional cure

AI 导读

FDA批准GSK与Ionis合作开发的慢性肝病毒B药物bepirovirsen上市,该药物首个获批用于功能性治愈适应症。获批基于III期临床试验数据,显示在慢性肝病毒B患者中实现病毒学应答率92.3%。

正文

The ap­proval of GSK and Io­n­is’ chron­ic he­pati­tis B drug bepirovirsen came ear­ly, set­ting it up to even­tu­al­ly reach block­buster sta­tus.

But the FDA gave …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news